EA201001138A1 - Антибактериальные композиции - Google Patents
Антибактериальные композицииInfo
- Publication number
- EA201001138A1 EA201001138A1 EA201001138A EA201001138A EA201001138A1 EA 201001138 A1 EA201001138 A1 EA 201001138A1 EA 201001138 A EA201001138 A EA 201001138A EA 201001138 A EA201001138 A EA 201001138A EA 201001138 A1 EA201001138 A1 EA 201001138A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- amino acid
- cys
- ser
- acid sequence
- rich repeat
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000001413 amino acids Chemical group 0.000 abstract 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 210000004901 leucine-rich repeat Anatomy 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
В заявке описан выделенный белок для применения в качестве антимикробного агента, который включает множество доменов с обогащенными лейцином повторами (leucine rich repeat - LRR), причем каждый LRR домен независимо включает аминокислотную последовательность формулы (I): (F1LxxLxL(xxZ)F2 ), в которой F1 и F2 независимы, смежная аминокислотная последовательность содержит от 1 до 30 остатков; х может быть какой-либо аминокислотой; L может быть Leu, Ile, Val или Phe; Z может быть NxL или CxxL; N обозначает Asn, Thr, Ser или Cys; С обозначает Cys или Ser и Y=0 или 1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08150290 | 2008-01-15 | ||
| PCT/EP2009/050317 WO2009090168A1 (en) | 2008-01-15 | 2009-01-13 | Anti-bacterial compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201001138A1 true EA201001138A1 (ru) | 2011-02-28 |
Family
ID=39495862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201001138A EA201001138A1 (ru) | 2008-01-15 | 2009-01-13 | Антибактериальные композиции |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100286027A1 (ru) |
| EP (1) | EP2242763A1 (ru) |
| JP (1) | JP2011509966A (ru) |
| KR (1) | KR20100116612A (ru) |
| CN (1) | CN102037006A (ru) |
| AR (1) | AR070177A1 (ru) |
| AU (1) | AU2009204842A1 (ru) |
| BR (1) | BRPI0906517A2 (ru) |
| CA (1) | CA2711972A1 (ru) |
| CL (1) | CL2009000065A1 (ru) |
| EA (1) | EA201001138A1 (ru) |
| MX (1) | MX2010007727A (ru) |
| PE (1) | PE20091334A1 (ru) |
| TW (1) | TW200936155A (ru) |
| WO (1) | WO2009090168A1 (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9297811B2 (en) | 2010-03-10 | 2016-03-29 | National University Corporation Hamamatsu University School Of Medicine | Production of enteritis evoking causal factor by highly pathogenic oral bacteria and high sensitivity detection method therefor |
| EP3424945A1 (en) | 2011-12-19 | 2019-01-09 | Shanghai First People's Hospital | Small molecule polypeptide for preventing and restraining inflammation and application of same |
| US11369657B2 (en) | 2011-12-19 | 2022-06-28 | Shanghai First People's Hospital | Small molecule polypeptide for preventing and restraining inflammation and application of same |
| CN105176882B (zh) * | 2015-10-17 | 2018-09-21 | 福清市默克兽医院 | 一种牛摩氏摩根菌性关节炎灭活疫苗及其制备方法 |
| US20200172868A1 (en) * | 2017-07-19 | 2020-06-04 | Rubius Therapeutics, Inc. | Compositions and methods related to multimodal therapeutic cell systems for infectious disease |
| CN114671945A (zh) * | 2022-01-14 | 2022-06-28 | 长沙学院 | 一种草鱼细菌小肽识别受体及制备方法与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040293A (en) * | 1996-11-06 | 2000-03-21 | The Regents Of The University Of California | Clavanins |
-
2009
- 2009-01-13 CA CA2711972A patent/CA2711972A1/en not_active Abandoned
- 2009-01-13 AU AU2009204842A patent/AU2009204842A1/en not_active Abandoned
- 2009-01-13 EP EP09702260A patent/EP2242763A1/en not_active Withdrawn
- 2009-01-13 WO PCT/EP2009/050317 patent/WO2009090168A1/en not_active Ceased
- 2009-01-13 KR KR1020107017977A patent/KR20100116612A/ko not_active Withdrawn
- 2009-01-13 EA EA201001138A patent/EA201001138A1/ru unknown
- 2009-01-13 CN CN2009801023027A patent/CN102037006A/zh active Pending
- 2009-01-13 MX MX2010007727A patent/MX2010007727A/es unknown
- 2009-01-13 US US12/812,120 patent/US20100286027A1/en not_active Abandoned
- 2009-01-13 JP JP2010542607A patent/JP2011509966A/ja active Pending
- 2009-01-13 BR BRPI0906517A patent/BRPI0906517A2/pt not_active IP Right Cessation
- 2009-01-14 CL CL2009000065A patent/CL2009000065A1/es unknown
- 2009-01-14 TW TW098101271A patent/TW200936155A/zh unknown
- 2009-01-15 PE PE2009000046A patent/PE20091334A1/es not_active Application Discontinuation
- 2009-01-15 AR ARP090100122A patent/AR070177A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2242763A1 (en) | 2010-10-27 |
| WO2009090168A1 (en) | 2009-07-23 |
| PE20091334A1 (es) | 2009-09-18 |
| TW200936155A (en) | 2009-09-01 |
| AU2009204842A1 (en) | 2009-07-23 |
| CL2009000065A1 (es) | 2009-11-06 |
| KR20100116612A (ko) | 2010-11-01 |
| US20100286027A1 (en) | 2010-11-11 |
| AR070177A1 (es) | 2010-03-17 |
| MX2010007727A (es) | 2010-10-26 |
| JP2011509966A (ja) | 2011-03-31 |
| CA2711972A1 (en) | 2009-07-23 |
| BRPI0906517A2 (pt) | 2019-09-24 |
| CN102037006A (zh) | 2011-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201001138A1 (ru) | Антибактериальные композиции | |
| MA33277B1 (fr) | Dérivés de thiazole et leur utilisation comme antagonistes des récepteurs p2y12 | |
| MX2020013853A (es) | Compuestos innovadores. | |
| WO2006103037A3 (de) | ZUSAMMENSETZUNG ENTHALTEND β-DEFENSIN 2 | |
| CL2011001967A1 (es) | Compuestos derivados de carboxamida-azaheterociclica sustituida, inhibidores de p70s6k, proceso de preparacion de estos; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias y cancer; kit farmaceutico. | |
| WO2007091958A8 (en) | Novel antimicrobial peptides and use thereof | |
| MA38143A1 (fr) | Composition comprenant des agents de lutte biologique | |
| EA201991799A1 (ru) | Диспергируемые в воде составы | |
| EA201000329A1 (ru) | Циклические депсипептиды | |
| WO2020123816A3 (en) | Anellosomes and methods of use | |
| EA202090448A1 (ru) | Дигидрооксадиазиноны | |
| DE602004022056D1 (de) | Antibakterielle zusammensetzung, vor allem zur bekämpfung gramnegativer bakterien, umfassend ein peptid und ein vorteilhafterweise hydrophobes antibakterielles agens | |
| WO2010142551A8 (en) | Amino acid sequences directed against receptors to cytokines belonging to the il-17 family | |
| WO2011146922A3 (en) | Materials and methods for treatment of inflammation | |
| EA201000814A1 (ru) | 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств | |
| EA200970132A1 (ru) | Аналоги морфолинила и пирролидинила | |
| EA202090068A1 (ru) | Соединения, влияющие на синтез пигмента и их применение для лечения бактериальных заболеваний | |
| EA202190888A1 (ru) | Пептид для применения в косметике | |
| EP3441082A4 (en) | PEPTIDE WITH EFFECT TO INCREASE TELOMERASE ACTIVITY AND TELOMER EXTENSION AND COMPOSITION THEREFOR | |
| MX2010003192A (es) | Lactonas macrociclicas como fragancias. | |
| PL417980A1 (pl) | Nowe fosfotriazolowe analogi kapu końca 5' mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu | |
| MA20150279A1 (fr) | (r)-nifuratel, son utilisation pour le traitement d'infections et synthèse de (r) et (s)-nifuratel | |
| EA201992226A1 (ru) | Агонисты npra, композиции и их использование | |
| WO2011100688A8 (en) | Improved antagonists of muc1 | |
| BR112021025470A2 (pt) | Composições intensificadoras de fragrância |